Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMC 442846)

Published in J Clin Invest on January 01, 1992

Authors

D L Kaufman1, M G Erlander, M Clare-Salzler, M A Atkinson, N K Maclaren, A J Tobin

Author Affiliations

1: Department of Psychiatry and Behavioral Sciences, University of California Los Angeles 90024.

Articles citing this

Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care (2011) 2.75

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest (1994) 2.28

Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A (1992) 1.93

Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest (1993) 1.65

Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 1.37

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med (1993) 1.34

Viral trigger for type 1 diabetes: pros and cons. Diabetes (2008) 1.33

Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest (1993) 1.28

Chronic stress-induced neurotransmitter plasticity in the PVN. J Comp Neurol (2009) 1.22

The role of immunomodulation therapy in autoimmune diabetes. J Diabetes Sci Technol (2009) 1.15

Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest (1997) 1.14

Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med (1993) 1.13

Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest (1993) 1.09

Approaches in type 1 diabetes research: A status report. Int J Diabetes Dev Ctries (2009) 1.08

Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest (1993) 1.07

Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev (2012) 1.04

Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol (2012) 1.03

Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest (1993) 1.03

Islet autoantigens: structure, function, localization, and regulation. Cold Spring Harb Perspect Med (2012) 1.02

Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.01

T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med (1994) 1.00

Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest (1993) 0.97

Structure and alternative promoters of the mouse glutamic acid decarboxylase 67 gene. Biochem J (1997) 0.96

Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci U S A (1992) 0.96

Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders. Clin Exp Immunol (1999) 0.93

Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment. Front Endocrinol (Lausanne) (2013) 0.93

Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest (1993) 0.87

A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis (2014) 0.85

Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies. J Clin Microbiol (2006) 0.83

Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med (1994) 0.81

Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies. Clin Exp Immunol (1998) 0.80

Type 1 diabetes: A predictable disease. World J Diabetes (2015) 0.80

HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides. Immunology (2005) 0.79

Expression of glutamic acid decarboxylase (GAD) in the alpha, beta and delta cells of normal and diabetic pancreas: implications for the pathogenesis of type I diabetes. Clin Exp Immunol (1993) 0.78

IDDM: an islet or an immune disease? Diabetologia (1994) 0.78

WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus. Antimicrob Agents Chemother (1993) 0.78

Expression of GAD67 and novel GAD67 splice variants during human fetal pancreas development: GAD67 expression in the fetal pancreas. Endocr Pathol (2007) 0.77

Molecular biology of IDDM. Diabetologia (1994) 0.77

Novel detection of pancreatic and duodenal homeobox 1 autoantibodies (PAA) in human sera using luciferase immunoprecipitation systems (LIPS) assay. Int J Clin Exp Pathol (2013) 0.76

Incomplete immune response to coxsackie B viruses associates with early autoimmunity against insulin. Sci Rep (2016) 0.75

Mapping of B cell epitopes on steroid 17 alpha-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type I. Clin Exp Immunol (1994) 0.75

Enterovirus and type 1 diabetes: What is the matter? World J Diabetes (2015) 0.75

Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma. J Cancer (2016) 0.75

GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus. Innov Clin Neurosci (2011) 0.75

Articles cited by this

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol (1986) 55.34

The scanning model for translation: an update. J Cell Biol (1989) 31.23

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71

Molecular mimicry and autoimmune disease. Cell (1987) 5.31

Immunology. The ins and outs of antigen processing and presentation. Nature (1986) 4.08

A molecular basis for MHC class II--associated autoimmunity. Science (1988) 3.75

Two genes encode distinct glutamate decarboxylases. Neuron (1991) 3.68

Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med (1979) 3.62

Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol (1990) 3.35

Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature (1989) 3.02

The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. J Gen Virol (1987) 3.01

Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem (1991) 2.66

Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature (1982) 2.58

Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature (1989) 2.50

Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J Neurosci (1988) 2.32

Autoimmune diseases: the failure of self tolerance. Science (1990) 2.24

Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest (1987) 2.09

Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94

Glutamic acid decarboxylase cDNA: nucleotide sequence encoding an enzymatically active fusion protein. J Neurosci (1987) 1.78

64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet (1990) 1.70

Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid. Science (1986) 1.60

Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med (1987) 1.58

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med (1990) 1.53

The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia (1988) 1.41

Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med (1980) 1.39

Genetic control of autoimmunity in type 1 diabetes. Immunol Today (1990) 1.35

Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science (1984) 1.31

Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis (1985) 1.29

gamma-Aminobutyric acid outside the mammalian brain. J Neurochem (1990) 1.26

The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology. Epidemiol Rev (1980) 1.25

Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbiol Immunol (1989) 1.21

Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes (1988) 1.08

Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet (1985) 1.08

Induction of diabetes by cumulative environmental insults from viruses and chemicals. Nature (1980) 1.03

Cellular and subcellular localization of an Mr 64,000 protein autoantigen in insulin-dependent diabetes. J Biol Chem (1990) 0.99

Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes (1986) 0.97

How, when, and why to predict IDDM. Diabetes (1988) 0.93

Initial pathogenic events in IDDM. Diabetes (1989) 0.92

Predicting type I diabetes. Diabetes Care (1990) 0.92

Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group. Diabetes (1982) 0.87

Purification and characterization of a strain of coxsackievirus B4 of human origin that induces diabetes in mice. J Med Virol (1988) 0.86

Insulin-dependent (juvenile-onset, type 1) diabetes mellitus Coxsackie B viruses revisited. Prog Med Virol (1987) 0.83

Effect of coxsackievirus B4 infection in mice on expression of 64,000-Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes (1988) 0.82

Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM. Diabetes Care (1989) 0.80

[Myocarditis and insulitis following coxsackie virus infection]. Z Kardiol (1976) 0.78

Articles by these authors

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (1993) 5.47

Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med (1999) 5.12

Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature (1998) 4.10

The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med (1994) 3.71

Two genes encode distinct glutamate decarboxylases. Neuron (1991) 3.68

DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80

Molecular biology of GABAA receptors. FASEB J (1990) 2.66

Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem (1991) 2.66

Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) (1981) 2.66

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med (1996) 2.35

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest (1994) 2.28

Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci (1994) 2.24

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med (1996) 2.06

Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia (2010) 2.04

Carbonic anhydrase from parsley leaves. J Biol Chem (1970) 2.03

Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A (1992) 1.93

The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res (1991) 1.93

Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol (1999) 1.91

Early infant diets and insulin-dependent diabetes. Lancet (1996) 1.86

Glutamic acid decarboxylase cDNA: nucleotide sequence encoding an enzymatically active fusion protein. J Neurosci (1987) 1.78

Localization of the heparin-binding site on complement factor H. J Biol Chem (1991) 1.77

Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med (1993) 1.75

Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet (1992) 1.73

Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J (2001) 1.73

Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes (1987) 1.72

IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1996) 1.71

64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet (1990) 1.70

Synergistic activation of dynamin GTPase by Grb2 and phosphoinositides. J Biol Chem (1998) 1.67

Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit. J Biol Chem (1999) 1.62

Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid. Science (1986) 1.60

Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency. J Pediatr (1986) 1.59

Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol (1983) 1.58

Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest (1995) 1.55

Maturity-onset diabetes of youth in black Americans. N Engl J Med (1987) 1.53

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med (1990) 1.53

Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes (1990) 1.51

Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A (1996) 1.51

A novel alpha subunit in rat brain GABAA receptors. Neuron (1989) 1.51

Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. Autoimmunity (1988) 1.48

Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial. Br J Cancer (2011) 1.47

Distribution of developmentally regulated hemoglobins in embryonic erythroid populations. Dev Biol (1979) 1.47

Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes (2000) 1.46

TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc Natl Acad Sci U S A (2000) 1.46

Cloning differentially expressed mRNAs. Nat Biotechnol (1996) 1.44

Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet (1995) 1.42

Different distributions of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J Neurosci Res (1993) 1.42

Immunotherapy in pre-type 1 diabetes mellitus. Diabetologia (1990) 1.39

Cellular immune reactivities in women with silicone breast implants: a preliminary investigation. Ann Allergy Asthma Immunol (1997) 1.39

Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol (1998) 1.38

Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes. Diabetes (2001) 1.34

Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem (1993) 1.33

Correlation between self-association modes and GTPase activation of dynamin. J Protein Chem (1999) 1.33

The diagnosis of insulitis in human type 1 diabetes. Diabetologia (2013) 1.33

Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8. Hum Mol Genet (1996) 1.31

Interactions of RecF protein with RecO, RecR, and single-stranded DNA binding proteins reveal roles for the RecF-RecO-RecR complex in DNA repair and recombination. Proc Natl Acad Sci U S A (1996) 1.30

Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr (1981) 1.30

Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J Autoimmun (1999) 1.30

Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest (1993) 1.28

Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells. J Thromb Haemost (2009) 1.26

Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods. J Comp Neurol (1993) 1.26

Increased expression of glutamate decarboxylase (GAD(67)) in feline lumbar spinal cord after complete thoracic spinal cord transection. J Neurosci Res (2000) 1.25

Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction. J Neurosci (1994) 1.25

Intranuclear distribution of herpes simplex virus type 2 DNA synthesis: examination by light and electron microscopy. J Gen Virol (1983) 1.24

Hyper-responsive phenotype in localized aggressive periodontitis. J Dent Res (2009) 1.23

Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108. Diabetologia (2006) 1.21

Chronic intermittent ethanol treatment in rats increases GABA(A) receptor alpha4-subunit expression: possible relevance to alcohol dependence. J Neurochem (1997) 1.21

Immune-associated nucleotide-1 (IAN-1) is a thymic selection marker and defines a novel gene family conserved in plants. J Immunol (1999) 1.21

Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients. J Pediatr (1973) 1.20

Uniqueness and redundancy in GABA production. Perspect Dev Neurobiol (1998) 1.20

Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther (2000) 1.19

Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med (1993) 1.19

Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia (1999) 1.17

Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes. Diabetes (1982) 1.16

Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther (2003) 1.14

Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther (2004) 1.14

Adrenal autoantibodies and Addison disease in insulin-dependent diabetes mellitus. J Pediatr (1980) 1.13

Amperometric monitoring of chemical secretions from individual pancreatic beta-cells. Anal Chem (1993) 1.12

Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J Clin Endocrinol Metab (1986) 1.12

The fine structure of cells infected with temperature-sensitive mutants of herpes simplex virus type 2. J Gen Virol (1978) 1.12

Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med (1986) 1.11

Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care (2001) 1.11

Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Proc Natl Acad Sci U S A (1993) 1.10

Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes (1980) 1.09

Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet (1995) 1.09

Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol (1996) 1.08

Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes (1988) 1.08

Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes (1992) 1.08

Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity (1994) 1.08